Bernard Delbecque, EFAMA

Long-term UCITS net sales surge to EUR53 billion in January 2013

UCITS experienced a jump in net inflows in January to EUR49 billion, up from EUR1 billion recorded in December, reflecting a surge in net sales of long-term UCITS and a reduction in net outflows from money market funds, according to European Fund and Asset Management Association’s (EFAMA) latest Investment Fund Industry Fact Sheet.

Net sales of long-term UCITS (UCITS excluding money market funds) increased substantially to record net inflows of EUR53 billion, up from EUR35 billion in December. 
 
Net sales of equity funds continued to rise to reach EUR21 billion, compared EUR14 billion in December. Bond funds also recorded higher net inflows of EUR19 billion, rising from from EUR14 billion in December, while balanced funds saw greater inflows of EUR11 billion from EUR7 billion in December.
 
Net outflows from money Market funds fell to EUR5 billion compared to EUR33 billion in December.  
 
otal non-UCITS recorded net sales of EUR17 billion, down from EUR30 billion of net inflows witnessed in December. Special funds (funds reserved to institutional investors) recorded reduced net inflows amounting to EUR15 billion, compared to EUR27 billion in December.
 
Total assets of UCITS stood at EUR6,395 billion at end January 2013, representing a 0.7 percent increase since end December 2012.  Total assets of non-UCITS enjoyed an increase of 0.3 percent in January to stand at EUR2,557 billion at month end.
 
Bernard Delbecque (pictured), Director of Economics and Research at EFAMA, says: “A perceived reduction in global stock market uncertainty supported by stronger financial market confidence strengthened investor sentiment in January, leading to the best month for net sales of long-term UCITS since EFAMA began collecting monthly data in October 2008.”

Further reading



Upcoming events

57 min 56 sec from now - Amsterdam
1 day 57 min from now - London
1 week 1 day from now - London
1 week 1 day from now - London
1 week 1 day from now - Cartegena

Upcoming training